The use of new incretine analogues injected at the interval of one to two weeks is the most important strategy for the treatment of obese type 2 diabetic patients and perhaps also of type 1 diabetic patients even in combination with insulin.
The use of new incretine analogues injected at the interval of one to two weeks is the most important strategy for the treatment of obese type 2 diabetic patients and perhaps also of type 1 diabetic patients even in combination with insulin. (en)